Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management
about
A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.Harms of cervical cancer screening in the United States and the Netherlands.Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?
P2860
Q36169189-E11D0D28-6A2C-44DE-8A11-911990FAE9ECQ37407506-EE829C3E-AE15-46D0-BF0E-FB6F9035F936Q38706590-3983A32C-651C-4C6C-801B-3E02D67C115AQ38789321-81AD9631-BD26-4FB1-8CFA-2E26BDDEE2C9Q39172644-6C494A1B-65C1-4B66-82CE-01BB3D4642E6Q39204728-7D5949AF-1137-4371-B1EE-126F4B73B2A6Q47239356-42EC4FF2-A8B6-482D-BB75-F11B350D5390Q47619776-212F49C7-8E19-49D7-AA90-2C4768144313Q55262796-60C7011F-7B95-4AE5-94FF-03CF0F7327BF
P2860
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Human papillomavirus testing 2 ...... subsequent clinical management
@ast
Human papillomavirus testing 2 ...... subsequent clinical management
@en
type
label
Human papillomavirus testing 2 ...... subsequent clinical management
@ast
Human papillomavirus testing 2 ...... subsequent clinical management
@en
prefLabel
Human papillomavirus testing 2 ...... subsequent clinical management
@ast
Human papillomavirus testing 2 ...... subsequent clinical management
@en
P2093
P2860
P356
P1476
Human papillomavirus testing 2 ...... subsequent clinical management
@en
P2093
Alan Waxman
Debbie Saslow
Jack Cuzick
Michael Robertson
New Mexico HPV Pap Registry Steering Committee
Orrin Myers
Philip E Castle
Walter Kinney
William C Hunt
P2860
P304
P356
10.1002/IJC.29337
P577
2014-12-01T00:00:00Z